As a result, measurement of copeptin levels as a biomarker allowed the possibility of researching the role of AVP in clinical applications.10,11 Studies to date have shown that copeptin is not limited to its role in posterior hypophysis function, but simultaneously is a marker of systemic circulation disorder in liver diseases and is associated with prognosis.12,13. The gene discussed is AVP; the disease is liver disorder.